The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review
Vera L Alves, João L Gonçalves, Joselin Aguiar, H. Teixeira, J. Câmara
Critical Reviews in Toxicology May 27, 2020 DOI: 10.1080/10408444.2020.1762539 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Key findings | Synthetic cannabinoids are the largest class of drugs detected through the EU Early Warning System, with 190 substances notified from 2008 to 2018 and about 280 reported worldwide to the United Nations Office on Drugs and Crime. They are more potent than natural cannabis and act as full agonists at cannabinoid receptors, and have been associated with deaths and acute intoxications in Europe. The authors argue they continue to challenge current drug policy models. |
Abstract
Abstract The word “cannabinoid” refers to every chemical substance, regardless of structure or origin, that joins the cannabinoid receptors of the body and brain and that have similar effects to those produced by the Cannabis plant and based on their source of production, cannabinoids can be classified into endocannabinoids, phytocannabinoids and synthetic cannabinoids. Synthetic cannabinoids represent the largest class of drugs detected through the EU Early Warning System with a total of 190 substances notified from 2008 to 2018 and about 280 have been reported worldwide to the United Nations Office on Drugs and Crime. Sprayed on natural herb mixtures with the aim to mimic the euphoria effect of cannabis and sold as “herbal smoking blends” or “herbal incense” under brand names like “Spice” or “K2”, synthetic cannabinoids are available from websites for the combination with herbal materials or more recently, for the use in e-cigarettes. Currently labeled as “not for human consumption” to circumvent legislation, their legal status varies by country with many government institutions currently pushing for their control. However, due to the emergence of new substances, it requires a constant update of the list of controlled drugs. Little is known about how these substances work and their toxic effects in humans and the same product could vary not only in the amount and in the type of substance added. In the last years, synthetic cannabinoids have been associated with deaths and acute intoxications in Europe and, despite a range of new measures introduced in this area, continue to represent a challenge to current drug policy models. These synthetic substances are much more potent than natural cannabis, as well as displayed greater efficacy, acting as full agonists at the cannabinoid receptors. It is possible that, along with being highly potent, some may also have long half-lives, potentially leading to a prolonged psychoactive effect. The present work provides a review on existing literature about the development of synthetic cannabinoids as substances of abuse, current patterns of abuse and their legal status, chemical classification, and some pharmacological and toxicological properties.
Citations in the library
Cited by 13
- Subtle Structural Modification of a Synthetic Cannabinoid Receptor Agonist Drastically Increases its Efficacy at the CB1 Receptor ACS Chemical Neuroscience October 17, 2023
- Comparison between pediatric and adult acute natural cannabinoids toxicity: A 5-year retrospective study with special consideration of acute synthetic cannabinoids toxicity. Toxicology Reports June 1, 2025
- Evaluating Delta-8-THC-Induced Psychosis: A Systematic Review. Clinical Neuropharmacology
- Pediatric Brain on Cannabinoids: Adverse Effects of Cannabinoid Products in Children and Adolescents IntechOpen eBooks August 3, 2022
- An emerging trend in Novel Psychoactive Substances (NPSs): designer THC Journal of Cannabis Research May 3, 2024
and 8 more in the library
Cites 20
- Beyond THC: The New Generation of Cannabinoid Designer Drugs Frontiers in Behavioral Neuroscience 2011
- Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants Frontiers in Neuroscience April 19, 2016
- New psychoactive substances of natural origin: A brief review Journal of Food and Drug Analysis April 18, 2017
- Psychosis and synthetic cannabinoids. Psychiatry Research October 2018
- Cannabinoids: from pot to lab International Journal of Medical Sciences August 6, 2018
and 15 more in the library